Human MYLIP, also known as Inducible Degrader of the LDL receptor (IDOL), GenBank Accession No. NM_013262, a.a. 2-445(end), with N-terminal His-FLAG-tag, MW=51.7 kDa, expressed in a baculovirus expression system.
Background
MYLIP is an E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of myosin regulatory light chain (MRLC), LDLR, VLDLR and LRP8. Its activity depends on E2 enzymes of the UBE2D family. Proteasomal degradation of MRLC leads to inhibition of neurite outgrowth. Acts as a sterol-dependent inhibitor of cellular cholesterol uptake by mediating ubiquitination and subsequent degradation of LDLR.
Immunogen Region
2-445(end)
Tag
N-terminal His-FLAG-tag
Formulation
40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 80 ug/ml FLAG peptide, and 20% glycerol.
Species
Human
Application
Useful for studying protein binding and screening small molecules for drug discovery.
Notes
Avoid freeze/thaw cycles.
GenBank
NM_013262
Mw(kda)
51.7 kDa
Synonyms
MYLIP, IDOL, Myosin Regulatory Light Chain Interacting Protein, Inducible Degrader Of The LDL-Receptor, BZF1,
Uniprot
Q8WY64
Shipping Temperature
-80°C (dry ice)
Format
Aqueous buffer solution
Storage
At least 6 months at -80°C.
Reference
1. Santos PC., et al. Lipids Health Dis. 2012;11:83. 2. Sorrentino V., et al. Eur Heart J. 2013;34(17):1292-7.